Serum Dihydrotestosterone (DHT) Test at Chughtai Lab

Serum Dihydrotestosterone (DHT) at Chughtai Lab

The Serum Dihydrotestosterone (DHT) test is a highly specialized endocrine investigation designed to measure the concentration of dihydrotestosterone in the bloodstream. Dihydrotestosterone is a potent androgenic hormone derived from testosterone through the enzymatic action of 5-alpha-reductase. Although it is present in much lower concentrations than testosterone, DHT possesses a significantly higher affinity for androgen receptors, making it the primary mediator of androgenic action in several target tissues, including the prostate gland, hair follicles, and external genitalia. At Chughtai Lab, Pakistan’s premier diagnostic network, this test is performed using advanced laboratory technologies to ensure clinical accuracy and reliability for patients nationwide.

Understanding the physiological role of DHT is crucial for diagnosing various endocrine, dermatological, and urological disorders. In males, DHT is essential for the prenatal development of external male genitalia and the subsequent physical changes that occur during puberty. In adult males, it plays a central role in prostate growth and the maintenance of male secondary sexual characteristics. In females, while present in much smaller quantities, DHT serves as a precursor for other hormones and can be a marker of androgen excess when elevated. Measuring serum DHT levels provides invaluable diagnostic value, helping clinicians differentiate between various forms of androgen insensitivity, evaluate hair loss patterns, investigate female virilization, and monitor the efficacy of therapeutic interventions targeting androgen pathways.

The diagnostic value of the Serum DHT test lies in its ability to provide a clear picture of peripheral androgen activity. While total and free testosterone levels are standard markers for androgen status, they do not always reflect the localized tissue-level conversion to DHT. Consequently, evaluating DHT levels is essential for a comprehensive endocrinological assessment. Chughtai Lab utilizes state-of-the-art chemiluminescent immunoassay (CLIA) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies to deliver precise quantification of this hormone, minimizing cross-reactivity with other circulating steroids and ensuring the highest standards of diagnostic accuracy.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is vital to ensure the clinical validity of your Serum Dihydrotestosterone test results. Patients are advised to adhere to the following guidelines prior to sample collection at Chughtai Lab:

• Medication Disclosure: Inform your prescribing physician and the laboratory staff of all medications, supplements, and herbal products you are currently taking. Specifically, drugs that inhibit 5-alpha-reductase (such as finasteride or dutasteride), anabolic steroids, testosterone replacement therapy, and oral contraceptives can significantly alter DHT levels.
• Fasting Requirements: While strict fasting is generally not mandatory for a Serum DHT test, a light fasting period of 8 to 12 hours may be recommended if other lipid or metabolic panels are being performed concurrently.
• Timing of Collection: Androgen levels exhibit diurnal variation, typically peaking in the early morning hours. Therefore, it is highly recommended to have your blood sample collected between 7:00 AM and 10:00 AM for the most accurate and standardized results.
• Avoid Biotin Supplements: High doses of biotin (Vitamin B7) can interfere with immunoassay-based testing methodologies, leading to falsely elevated or suppressed results. It is recommended to discontinue biotin supplements at least 72 hours before the test, under medical supervision.
• Hydration: Stay adequately hydrated by drinking plenty of water before the procedure, as this facilitates easier venous access.

During the Procedure

The Serum DHT test is a straightforward outpatient laboratory procedure involving a standard venipuncture. When you arrive at a Chughtai Lab collection center, the clinical process proceeds as follows:

• Patient Identification: The phlebotomist will verify your identity, check your doctor’s prescription, and confirm that all pre-test preparation guidelines have been followed.
• Positioning: You will be asked to sit comfortably in a specialized blood collection chair or lie down if you have a history of vasovagal syncope (fainting).
• Site Selection and Cleansing: The phlebotomist will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The selected site is then thoroughly cleansed with an antiseptic swab to prevent contamination.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. A small volume of blood is drawn into a vacuum-sealed collection tube (typically a serum separator tube or red-top tube). You may feel a brief, mild pinch or stinging sensation as the needle enters.
• Post-Collection Care: Once the sample is secured, the needle is carefully removed, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze to stop any bleeding. A small adhesive bandage is then applied.
• Safety and Duration: The entire collection process takes less than five minutes. Chughtai Lab strictly adheres to international biosafety standards, utilizing sterile, disposable equipment for every patient to eliminate any risk of infection.

When is a Serum Dihydrotestosterone (DHT) Test Performed?

Investigating Male Pattern Baldness (Androgenetic Alopecia)

Androgenetic alopecia is a genetically determined, progressive form of hair loss that affects both men and women. DHT is the primary androgen responsible for this condition; it binds to androgen receptors in susceptible hair follicles, leading to follicular miniaturization, a shortened anagen (growth) phase, and eventual hair loss. Physicians request a Serum DHT test to evaluate systemic androgen levels in individuals experiencing rapid or premature hair loss. This helps differentiate androgenetic alopecia from other forms of hair loss, such as telogen effluvium or alopecia areata, and guides targeted therapeutic strategies.

Evaluating Hirsutism and Virilization in Females

Hirsutism refers to the excessive growth of dark, coarse hair in females in areas where male-pattern hair growth typically occurs, such as the face, chest, and back. Virilization involves more severe signs of masculinization, including clitoromegaly, voice deepening, and increased muscle mass. These clinical presentations are often driven by excess androgen production. A Serum DHT test is requested alongside other hormones (like free testosterone and DHEA-S) to identify the source of androgen excess, such as Polycystic Ovary Syndrome (PCOS), congenital adrenal hyperplasia, or androgen-secreting tumors of the ovaries or adrenal glands.

Monitoring 5-Alpha-Reductase Inhibitor Therapy

5-alpha-reductase inhibitors, such as finasteride and dutasteride, are commonly prescribed to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia. These medications work by blocking the conversion of testosterone to DHT, thereby reducing systemic and tissue-specific DHT levels. Clinicians utilize the Serum DHT test to monitor patient compliance, assess the biochemical efficacy of the medication, and make informed dosage adjustments based on the degree of DHT suppression achieved.

Assessing Suspected 5-Alpha-Reductase Deficiency

5-alpha-reductase deficiency is a rare autosomal recessive intersex condition that affects male sexual development before birth and during puberty. Affected individuals are genetically male (46,XY) but may be born with ambiguous external genitalia due to the lack of DHT during fetal development. At puberty, they may experience virilization but will have persistently low DHT levels. A Serum DHT test, along with a testosterone-to-DHT ratio, is critical for diagnosing this genetic disorder in infants and adolescents presenting with atypical genital development.

Investigating Prostate Disorders and Benign Prostatic Hyperplasia (BPH)

The prostate gland is highly dependent on DHT for its growth and maintenance. Excessive DHT activity can contribute to the development of benign prostatic hyperplasia (BPH), leading to lower urinary tract symptoms (LUTS) such as urinary hesitancy, weak stream, and nocturia. In some clinical scenarios, evaluating serum DHT levels helps urologists understand the hormonal milieu driving prostate enlargement, especially when planning medical therapies aimed at shrinking prostate volume.

What Does a Serum Dihydrotestosterone (DHT) Test Detect?

The Serum DHT test provides precise quantitative data regarding circulating dihydrotestosterone levels. Clinically, this measurement can detect and indicate several physiological and pathological states:

• Elevated DHT in Females: Suggests androgen excess, commonly associated with Polycystic Ovary Syndrome (PCOS).
• Adrenal Hyperplasia: Elevated levels can indicate congenital or late-onset adrenal hyperplasia affecting steroidogenesis.
• Androgen-Secreting Tumors: Markedly elevated DHT can be a marker for rare ovarian or adrenal tumors.
• Idiopathic Hirsutism: Normal or elevated DHT levels in females presenting with hirsutism without ovarian or adrenal pathology.
• Androgenetic Alopecia Susceptibility: High-normal or elevated circulating DHT levels associated with progressive male or female pattern baldness.
• Benign Prostatic Hyperplasia (BPH): Elevated localized or systemic DHT levels contributing to prostate gland enlargement.
• Exogenous Androgen Use: Detection of suppressed or elevated DHT levels resulting from anabolic steroid abuse or hormone replacement therapy.
• Primary Hypogonadism in Males: Decreased DHT levels due to testicular failure or dysfunction.
• Secondary Hypogonadism in Males: Decreased DHT levels resulting from pituitary or hypothalamic disorders.
• 5-Alpha-Reductase Deficiency: Characterized by abnormally low DHT levels accompanied by a high testosterone-to-DHT ratio.
• Efficacy of Finasteride Therapy: Significant reduction in baseline DHT levels, indicating successful enzymatic inhibition.
• Efficacy of Dutasteride Therapy: Near-complete suppression of serum DHT, confirming dual-pathway 5-alpha-reductase inhibition.
• Delayed Puberty in Males: Subnormal DHT levels corresponding to delayed constitutional growth or hypogonadotropic hypogonadism.
• Precocious Puberty: Prematurely elevated DHT levels in children showing early secondary sexual development.
• Androgen Insensitivity Syndrome (AIS): Normal to elevated DHT levels in individuals with female phenotypes but male genotypes, indicating receptor-level resistance.
• Hepatic Dysfunction: Altered DHT metabolism and clearance due to severe liver disease or cirrhosis.
• Nutritional Deficiencies: Decreased DHT levels associated with severe protein-calorie malnutrition or eating disorders.
• Age-Related Androgen Decline: Gradually decreasing DHT levels in aging males, correlating with late-onset hypogonadism.
• Hyperthyroidism: Alterations in sex hormone-binding globulin (SHBG) levels, which can indirectly affect total and free DHT fractions.
• Hypothyroidism: Decreased metabolic clearance and altered binding capacity of circulating androgens.
• Adrenal Insufficiency: Decreased precursor availability leading to lower overall androgen synthesis, including DHT.
• Anorexia Nervosa: Severe endocrine suppression leading to diminished gonadotropin secretion and low DHT levels.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, accurate, and easily accessible diagnostic reports. Because the Serum Dihydrotestosterone (DHT) test is a specialized hormone assay requiring precise analytical techniques, the standard turnaround time is typically within 24 to 48 hours from the time of sample collection. Once the analysis is completed and verified by a consultant pathologist, patients are immediately notified via an automated SMS alert.

Reports can be accessed and downloaded digitally through multiple convenient channels. Patients can visit the official Chughtai Lab website and enter their patient ID and password, or utilize the user-friendly Chughtai Lab Mobile App available for iOS and Android devices. The app allows patients to view their complete diagnostic history, download PDF reports, and share them directly with their consulting physicians. Physical copies of the report can also be collected from any of the numerous Chughtai Lab collection centers located across Pakistan.

Serum Dihydrotestosterone (DHT) Findings Overview

The following table outlines the typical clinical parameters evaluated during a Serum DHT test, along with general reference ranges and potential abnormal findings:

Parameter Evaluated	Normal Findings (Approximate Reference Range)	Possible Abnormal Findings
Adult Male Serum DHT	112 to 955 pg/mL (varies by age and assay)	Elevated in BPH, androgen abuse; Decreased in hypogonadism, 5-alpha-reductase deficiency.
Adult Female Serum DHT	24 to 368 pg/mL (varies by menopausal status)	Elevated in PCOS, hirsutism, ovarian/adrenal tumors; Decreased in adrenal insufficiency.
Prepubertal Children DHT	< 50 pg/mL (highly age-dependent)	Elevated in precocious puberty, CAH; Decreased in delayed puberty, genetic disorders.
Testosterone to DHT Ratio	Typically < 10:1 to 12:1 in adult males	Significantly elevated (> 20:1) in cases of 5-alpha-reductase deficiency.
Postmenopausal Female DHT	Typically lower than premenopausal levels	Elevated in late-onset virilizing syndromes or androgen-producing neoplasms.
Patients on 5-ARI Therapy	Significantly suppressed from baseline levels	Inadequate suppression suggests non-compliance or drug resistance.
Free DHT Fraction	Corresponds to unbound, biologically active hormone	Altered by changes in Sex Hormone-Binding Globulin (SHBG) levels.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum Dihydrotestosterone (DHT)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, biochemists, and clinical technologists specializing in complex endocrine assays.
• Patient-Focused Care: Chughtai Lab prioritizes patient comfort, safety, and confidentiality at every step of the diagnostic journey.
• Quality Diagnostic Services: We adhere to strict internal and external quality control protocols to ensure the highest accuracy of all hormone measurements.
• Professional Reporting: Reports are presented in a clear, structured, and easy-to-understand format, complete with age- and sex-specific reference ranges.
• Modern Diagnostic Approach: Utilizing state-of-the-art automated immunoassay platforms and advanced testing methodologies to minimize human error.
• Comfortable Environment: Our collection centers nationwide are designed to provide a clean, welcoming, and stress-free experience for patients.
• Convenient Locations: With an extensive network of diagnostic centers and home sample collection services across Pakistan, accessing quality healthcare has never been easier.
• Commitment to Accurate Diagnosis: We understand the clinical significance of endocrine testing and are dedicated to delivering results you and your physician can trust.